Taken together, these results demonstrate that the Sema3A/NRP1 signaling axis is associated with poor prognosis, is particularly elevated in the mesenchymal subtype, and is correlated with TGF-β activity in a large glioma cohort (Figure 10 and Supplemental Figure 5). The gene discussed is NRP1; the disease is glioma.